Video

Mindy Mintz Mordecai on the Association Between Acid Reflux and Esophageal Cancer

Mindy Mintz Mordecai, founder, president, and CEO of the Esophageal Cancer Action Network (ECAN), discusses the link between acid reflux and esophageal cancer.

Mindy Mintz Mordecai, founder, president, and CEO of the Esophageal Cancer Action Network (ECAN), discusses the link between acid reflux and esophageal cancer.

ECAN has been working to not only spread awareness of the risk of esophageal cancer posed by reflux, but also spread awareness of the fact that reflux is not just heartburn. Mordecai explains that while esophageal cancer is the fastest increasing cancer among American men, a public opinion poll conducted by ECAN showed only 14% of Americans know that reflux can cause cancer.

Part of ECAN’s efforts include filing a petition with the FDA urging it to change the label on over-the-counter reflux medication to state that anyone who takes the medication may be at risk for esophageal cancer, and further, taking medication does not eliminate the risk of developing cancer.

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.